Mark S. Cohen > Pearl Cohen Zedek Latzer Baratz > Tel Aviv, Israel > Lawyer Profile
Pearl Cohen Zedek Latzer Baratz Offices
Azrieli Sarona Tower, 121 Menachem Begin Road
Tel Aviv, 6701203
- Go to...
Mark S. Cohen
Mark Cohen is a founder of Pearl Cohen Zedek Latzer Baratz, Senior Partner, Chair of the Life Science Practice Group, and a member of the firm’s Executive Committee.
Mark’s practice focuses on patent prosecution in the pharmaceutical, chemical, biological, and medical device areas, as well as licensing and client counseling. He is well-versed in all aspects of patent prosecution, intellectual property management, strategic advice, technology assessment, and licensing matters. His work includes management of large patent portfolios, negotiating terms, drafting agreements, and counseling start-ups. He has been involved in large due diligence matters; infringement, validity and patentability opinions; licensing matters; and opposition proceedings in Europe.
Mark Cohen is a Board Member of Masthercell Global Inc. a subsidiary of Orgenesis Inc. (Nasdaq: ORGS), a manufacturer, service provider and developer of advanced cell therapies. Mark Cohen was Vice Chairman of the Board, and Chairman of the Governance and Nominating Committee of Akari Therapeutics, Plc. (NASDAQ: AKTX) an emerging biopharmaceutical company that is developing anti-complement and anti-inflammatory molecules as life-transforming treatments for a wide range of severe and orphan autoimmune and inflammatory diseases.
He has published in Nature Biotechnology and various patent trade journals. He has lectured at the Practicing Law Institute (PLI) and the American Conference Institute on general patent topics, and at other venues in the US and Europe on patent issues in the biotechnology/ pharmaceutical area. Mark also served as Editor-in-Chief of the University of Baltimore Intellectual Property Law Journal.
His clients that he represents range from start-up companies to Fortune 500 companies. He represents global corporation, as well as mid-size companies; private companies, technology transfer offices of academic institutions; fundamental institutional funds; and start-up companies in the biotechnology/biopharmaceutical/immunotherapy area.
University of Baltimore School of Law, J.D., 1993
New York University, M.Sc. Biology, 1990
Rutgers University, B.A. Biochemistry, 1989
Pearl Cohen Zedek Latzer Baratz represents clients from numerous industries before domestic, US, and European patent offices, and acts on patent matters for some of the largest international pharmaceutical companies. A renowned IP practitioner with three decades of experience, practice co-head Zeev Pearl assists companies from their setup in Israel through the prosecution of their patents to the management of their overall IP portfolio. Co-head and prominent chair of the life science practice group Mark S. Cohen focuses on patent prosecution in the pharmaceutical, chemical, biological, and medical sectors. The firm’s trade mark and designs group is headed by Dor Cohen Zedek, who – as several others in the team – is admitted to practice in both Israel and the US, and handles the enforcement and management of trade marks and designs worldwide. Yoav Alkalay approaches client’s matters from a commercial angle, focusing on strategic development of IP assets and portfolios. Idan Frydman left the firm.
Leveraging its impressive international footprint with offices in the US, Europe, the UK, and Asia, Pearl Cohen Zedek Latzer Baratz is best placed to assist US and domestic pharmaceutical, medical cannabis, tech transfer companies and healthcare start-ups on IP, corporate law, securities, and employment matters. It handles a steady flow of contentious and non-contentious patent matters which the firm particularly excels. Managing partner Zeev Pearl is recommended for IP portfolios, licensing, litigation, and commercial transactions. Co-head Mark S. Cohen focuses on patent prosecution and licensing transactions. Yael Baratz also jointly heads the team, and is recommended for licensing, technology licensing and collaborations, and M&A transactions.
Pearl Cohen Zedek Latzer Baratz‘s market leading position is built on the combination of prominent work in licensing, tech transfers, and ongoing corporate support with its multi-jurisdictional presence in Israel, the US, and the UK. Zeev Pearl and Mark S. Cohen are the founding partners and practice co-heads. Pearl has three decades of experience in handling IP matters for multinationals in Israel, while Cohen is renowned for his expertise in commercialising life sciences technology. Senior partner Yael Baratz chairs the corporate and licensing group and is also co-chair of the Israel Bar Association’s Science and Technology Committee.
- Intellectual property: commercial/transactions - Israel > Intellectual property
- Intellectual property: filing/prosecution - Israel > Intellectual property
- Healthcare and life sciences - Israel
Top Tier Firm Rankings
- Intellectual property > Intellectual property: commercial/transactions
- Intellectual property > Intellectual property: filing/prosecution